Jennison Associates LLC
http://www.jennison.com/DesktopDefault.aspxJennison Associates is an investment management firm founded in 1969. The firm manages over $86 billion for institutions and private clients through managed accounts and commingled vehicles including mutual funds. The firm's expertise includes a range of equity strategies across styles and market capabilities, as well as fixed income strategies.
View Older Stories View More Recent Stories
-
Form SC 13G HERSHA HOSPITALITY TRUST Filed by: JENNISON ASSOCIATES LLC
-
Form SC 13G Fenix Parts, Inc. Filed by: JENNISON ASSOCIATES LLC
-
Form SC 13G Chatham Lodging Trust Filed by: JENNISON ASSOCIATES LLC
-
Ovid Therapeutics Announces Election of Industry Leader Douglas E. Williams, Ph.D., to Its Board of Directors
-
Vanguard Announces Advisory Changes For Two Active Equity Funds
-
Wendy's (WEN) Adds Dennis Kass, Matthew Peltz as Directors
-
The Wendy's Company Announces Addition of Dennis Kass and Matthew Peltz to Board of Directors
-
Prudential Investment Management experts see a ‘universe of opportunities’ for investors in 2016
-
Form SC 13G/A Kindred Biosciences, Filed by: JENNISON ASSOCIATES LLC
-
Ovid Therapeutics Announces Election of Bart Friedman to Its Board of Directors
-
Bolstered By Recent Leadership Appointments, Continuity Logic Breaks New Ground in the GRC Enterprise Software Universe
-
Form 13F-HR JENNISON ASSOCIATES LLC For: Sep 30
-
Ovid Therapeutics Announces Appointment of Dr. Anna Kazanchyan to Senior Vice President, Business Development
-
Form SC 13G/A Retrophin, Inc. Filed by: JENNISON ASSOCIATES LLC
-
Ovid Therapeutics Appoints Dr. Jerome B. Zeldis to Its Scientific Advisory Board
-
Ovid Therapeutics Appoints Dr. Karen Bernstein to its Board of Directors
-
Corvus Pharmaceuticals Completes $75 Million Series B Financing
-
Form SC 13G/A FLUIDIGM CORP Filed by: JENNISON ASSOCIATES LLC
-
Form SC 13G/A Flexion Therapeutics Filed by: JENNISON ASSOCIATES LLC
-
Syndax Raises $80 Million In Series C Financing
-
WAVE Life Sciences Raises $66 Million in Series B Financing
-
CytoSorbents Reports Steady Growth in Q2 2015
-
Ovid Therapeutics Completes Oversubscribed $75 Million Series B Financing
-
Editas Medicine Raises $120 Million to Advance Genome Editing
-
Form SC 13G NN INC Filed by: JENNISON ASSOCIATES LLC
-
Form SC 13G NextEra Energy Partners, Filed by: JENNISON ASSOCIATES LLC
-
Form SC 13G/A Otonomy, Inc. Filed by: JENNISON ASSOCIATES LLC
-
Form SC 13G/A ARATANA THERAPEUTICS, Filed by: JENNISON ASSOCIATES LLC
-
Form 13F-HR JENNISON ASSOCIATES LLC For: Jun 30
-
Veteran Healthcare Analyst Michael G. Bator Joins CytoSorbents Board of Directors
-
Afferent Pharmaceuticals Raises $55 Million in Oversubscribed Crossover Financing
-
REGENXBIO Secures $70.5 Million in a Mezzanine Financing
-
REGENXBIO Secures $70.5 Million in a Mezzanine Financing
-
Form SC 13G/A OvaScience, Inc. Filed by: JENNISON ASSOCIATES LLC
-
Form 13F-HR JENNISON ASSOCIATES LLC For: Mar 31
-
Mittleman Brothers, LLC Announces the Hiring of Laura Kate Garner as Chief Compliance Officer
-
CORRECTING and REPLACING Mittleman Brothers, LLC Announces the Hiring of Laura Kate Garner as Chief Compliance Officer
-
Dimension Therapeutics Secures $65 Million in Oversubscribed Series B Financing
-
Form SC 13G/A ASSEMBLY BIOSCIENCES, Filed by: JENNISON ASSOCIATES LLC
-
Natera, Inc., Non-Invasive Genetic Testing Leader, Secures $55 Million in Private Financing
-
Aeglea Biotherapeutics Raises $44 Million in Series B Financing
-
Form SC 13G/A SPLUNK INC Filed by: JENNISON ASSOCIATES LLC
-
Form SC 13G/A DERMA SCIENCES, INC. Filed by: JENNISON ASSOCIATES LLC
-
Form SC 13G CymaBay Therapeutics, Filed by: JENNISON ASSOCIATES LLC
-
Form SC 13G/A Retrophin, Inc. Filed by: JENNISON ASSOCIATES LLC
-
Form SC 13G/A Independence Contract Filed by: JENNISON ASSOCIATES LLC
-
Form SC 13G/A Great Lakes Dredge & Filed by: JENNISON ASSOCIATES LLC
-
Form SC 13G OvaScience, Inc. Filed by: JENNISON ASSOCIATES LLC
-
Form SC 13G/A Kindred Biosciences, Filed by: JENNISON ASSOCIATES LLC
-
Form SC 13G/A ARATANA THERAPEUTICS, Filed by: JENNISON ASSOCIATES LLC

